Publications

  • Home
  • Publications
  • CALIPSO: revolutionizing the management of bioproduction processes in healthcare

CALIPSO: revolutionizing the management of bioproduction processes in healthcare

Paris (France) – September 16th, 2021 – Sanofi, Capgemini, Ypso-Facto, GPC Bio, CEA, CentralSupelec announce the launch of the project CALIPSO !

  • by Ypso-Facto
  • September 16, 2021
CALIPSO: revolutionizing the management of bioproduction processes in healthcare

 

  • A structuring R&D project for French medical research, financed and coordinated by a consortium of high-profile industrial and public actors.
  • An essential mobilisation to accelerate access to new treatments at an acceptable cost, to ensure France’s competitiveness and its health independence.

For more information, download the pdf below or contact us : contact@ypso-facto.com 

 



Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.

Learn more

Contact Us
© Ypso-Facto 2014 - Powered by Ealys | Legal Information